Breast Cancer Study
SWOG SO307: Phase III Trial of Bisphosphates As Adjuvant Therapy for Primary Breast Cancer
Protocol ID
08-306
Protocol Description
This study is investigational and is being done to find out if adding a drug (a bisphosphonate) to hormonal therapy or chemotherapy will help prevent cancer from spreading to the bones or other parts of the body. "Bisphosphonates" are drugs that prevent bone from breaking down. Low doses of bisphosphonate drugs are used to treat osteoporosis; higher doses of bisphosphonate drugs are used to treat cancer that has spread to the bone. Bisphosphonates have been shown to strengthen the bones in many patients who take them.
Eligibility Criteria
Patients with breast cancer
Primary Investigator(s)
- Lora Weiselberg, MD